The Effect of Certolizumab Pegol in Combination With Methotrexate on MRI Synovitis and Bone Edema and Patient Reported Outcomes as Measured Using an Automated Visit Manager System in Moderate to Severe Rheumatoid Arthritis Patients.
Phase of Trial: Phase III
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Certolizumab pegol (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PICS
- 01 Apr 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2010 New trial record